ANNA, Konieczna, Vendula NOVÁKOVÁ, Jiřina MEDALOVÁ, Erceg SLAVEN a Martin KLABUSAY. Thiazolidinediones Regulate the Level of ABC Transporters Expression on Lung Cancer Cells. Klinicka onkologie Journal. 2015, roč. 28, č. 6, s. 431-438. ISSN 0862-495X. Dostupné z: https://dx.doi.org/10.14735/amko2015431.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Thiazolidinediones Regulate the Level of ABC Transporters Expression on Lung Cancer Cells
Autoři ANNA, Konieczna (203 Česká republika), Vendula NOVÁKOVÁ (203 Česká republika), Jiřina MEDALOVÁ (203 Česká republika, domácí), Erceg SLAVEN (203 Česká republika) a Martin KLABUSAY (203 Česká republika, garant).
Vydání Klinicka onkologie Journal, 2015, 0862-495X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30105 Physiology
Stát vydavatele Česká republika
Utajení není předmětem státního či obchodního tajemství
Kód RIV RIV/00216224:14310/15:00086936
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.14735/amko2015431
Klíčová slova anglicky Thiazolidinedion; ABC Transporters; Lung Cancer
Štítky AKR
Změnil Změnila: Mgr. Jiřina Medalová, Ph.D., učo 176525. Změněno: 13. 3. 2018 11:11.
Anotace
ATP binding cassette (ABC) transporters related to multidrug resistance (MDR) actively efflux various xenobiotics from the cells across the cell membrane and decrease a drugs efficiency. Lung cancer is the leading cause of death among all types of cancer in the Czech Republic, and its incidence is still rising. Ciglitazone, rosiglitazone and troglitazone belonging to PPARgama agonist family (formerly used in diabetes mellitus treatment) were selected to investigate their capability to influence expression of ABC transporters on lung cancer cells. Therefore, the effect of PPARgama of agonists on transcription of following ABC transporters was investigated: multidrug resistance protein 1 (MDR1), multidrug resistance-associated protein 1 (MRP1), and breast cancer resistance protein (BCRP). We have investigated if these PPARgama agonists are substrates of ABC transporters using HL60 and HL60 derived cell lines (HL60-MDR1, HL60-MRP1, PLB-BCRP) by cytotoxicity test WST-1. We have mapped the changes in mRNA expression level of those transporters in A549 and HEK293 cells after PPARgama agonists treatment using quantitative reverse transcription real-time PCR (qRT-PCR). All three PPARgama agonists serve as substrates to at least one ABC transporter under study.PPARgama activation correlates with the upregulation of PTEN, which may modulate the expression of ABC transporters via PI3K/Akt signaling pathway. We have shown that rosiglitazone and troglitazone inhibit mRNA expression of MDR1 transporter in both cell lines whereas the expression of MRP1 in HEK293 cell was up-regulated after rosiglitazone treatment and the expression of MDR1 was upregulated after ciglitazone treatment
VytisknoutZobrazeno: 19. 7. 2024 17:40